RHBDF2 and metabolic dysfunction-associated steatotic liver disease: The palmitoyltransferase ZDHHC3 exacerbates non-alcoholic fatty liver disease (NAFLD) by promoting the S-palmitoylation of inactive rhomboid protein 2, further highlighting the broader implications of palmitoylation in inflammatory conditions (103).